SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VaxGen Inc.-The 1st AIDS Vaccine in Phase 3 HumanTrials

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: glen who wrote (18)6/4/1999 5:48:00 AM
From: GPSite  Read Replies (1) of 250
 
Glen -- I'd like to believe that the FDA is as humanitarian and forward-thinking as your rationale for the 30% efficaciousness suggests, and your reasoning certainly is correct; however, my guess is that they have been under some (in)direct pressure to get a vaccine out there. There's been a low-level buzz about AIDSVAX for a while and it certainly has penetrated all levels of the medical and political world. I'm speculating, but I can just see the vaccine panel at the FDA looking around the table and saying "What's a level they can't miss?"

Not that I believe the vaccine is only 30% effective. Adding the second antigen (and working on a third)makes the prospects greater than that. When the FDA first looked at this vaccine, it was univalent.

Anyway, I've given up guessing where stocks are going to go; I'm not sure it matters with this issue because it's a vaccine for AIDS and sooner or later the light bulb will go on in the public mind; And we will be standing there holding a piece of history -- as well as the greatest investment we ever made.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext